Subtype
Colorectal Neoplasm
CI-CAN-00002404Explore in graph →
Non-malignant1,784 active trials21 approved drugs382 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002404Explore in graph →
Clinical trials
8,604 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05420584 | Neoadjuvant Arterial Embolization Chemotherapy Combined PD-1 Inhibitor for Locally Advanced Rectal Cancer(NECI) | unknown | Phase 2 | 83 | The Fourth Affiliated Hospital of Zhejiang University School of MedicineOTHER | 1 | May 11, 2023 | clinicaltrials |
| NCT05854394 | Effect of Multimodal Prehabilitation After Colorectal Cancer Surgery | unknown | N/A | 100 | Xiamen UniversityOTHER | 1 | May 11, 2023 |
| clinicaltrials |
| NCT05851235 | Prehabilitation in Geriatric Patients With Colorectal Neoplasia(PIGEON) | unknown | N/A | 25 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSOTHER | 1 | May 9, 2023 | clinicaltrials |
| NCT02974556 | Proactive Management of Endoperitoneal Spread in Colonic Cancer(PROMENADE) | unknown | Phase 3 | 140 | University of Roma La SapienzaOTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT03699761 | The Role of Pelvic Peritonization in Laparoscopic or Robotic Low Anterior Resection | unknown | N/A | 1,000 | Southwest Hospital, ChinaOTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT05845268 | Total Neoadjuvant Therapy Combined With Tislelizumab for Local Advanced of Middle and Low Rectal Cancer | unknown | Phase 2 | 102 | Beijing Friendship HospitalOTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT05099237 | Enhanced Monitoring for Better Recovery and Cancer Experience in Greater Manchester(EMBRaCE-GM) | unknown | N/A | 80 | Manchester University NHS Foundation TrustOTHER_GOV | 1 | May 3, 2023 | clinicaltrials |
| NCT05830890 | Sentinel Lymph Node Biopsy in Rectal Cancer | unknown | N/A | 87 | National Cancer Center, ChinaOTHER | 1 | Apr 28, 2023 | clinicaltrials |
| NCT05832372 | Esophagogastric Histopathology Potentially Guided Patients Younger Than 50 Years Old to Undergo Colonoscopy Earlier | unknown | — | 9,000 | Shandong UniversityOTHER | 0 | Apr 27, 2023 | clinicaltrials |
| NCT05833672 | Neoadjuvant Immunotherapy in Locally Advanced Colon Cancers | unknown | Phase 2 | 100 | fan liOTHER | 1 | Apr 27, 2023 | clinicaltrials |
| NCT05831488 | Assessing the Accuracy of Seismofit® as an Estimate of VO2 Peak in Patients With Hepato-pancreato-biliary, Colorectal, and Gastro-oesophageal Cancer(VERVE) | unknown | — | 35 | Royal Marsden NHS Foundation TrustOTHER | 1 | Apr 26, 2023 | clinicaltrials |
| NCT05825664 | Underwater Versus Conventional Endoscopic Mucosal Resection in the Treatment of Non-pedunculated Colorectal Polyps | unknown | N/A | 228 | University of Medicine and Pharmacy at Ho Chi Minh CityOTHER | 1 | Apr 24, 2023 | clinicaltrials |
| NCT05213741 | Feasibility Trial of Magnetic-assisted Colonoscope Platform | unknown | N/A | 10 | Taipei Medical University WanFang HospitalOTHER | 0 | Apr 20, 2023 | clinicaltrials |
| NCT05653934 | Use of VIrtual REAlity to Reduce Postoperative Anxiety and Pain After Surgery for Colorectal Cancer(VIREA) | unknown | N/A | 124 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Apr 19, 2023 | clinicaltrials |
| NCT05147545 | Impact of Exercise and Hyperlipidic Meal on Free Circulating DNA in Patients With Metastatic Colonic Cancer and Healthy Subjects(ASRHACOLS) | unknown | N/A | 60 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT05815290 | Cadonilimab in Locally Advanced MSI-H/dMMR Colorectal Cancer | unknown | Phase 2 | 50 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT05815303 | XELOX Combined With Cadonilimab Versus XELOX as Neoadjuvant Treatment for Locally Advanced, pMMR Rectal Cancer | unknown | Phase 2 | 92 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT05109130 | Change of Circulating Tumor Cells During Laparoscopic or Transanal Endoscopic Surgery for Rectal Cancer. | unknown | — | 100 | Sun Yat-sen UniversityOTHER | 1 | Apr 13, 2023 | clinicaltrials |
| NCT05245565 | Effects of Modified Precision Functional Sphincter-Preserving Surgery (PPS) on Ultralow Rectal Cancer | unknown | — | 120 | Shanghai 10th People's HospitalOTHER | 1 | Apr 13, 2023 | clinicaltrials |
| NCT05801211 | Colonic Resection or Stoma, or Self-expandable Metallic Stent for obstruCtive Left cOlon Cancer(CROSCO-1) | unknown | — | 434 | Azienda Sanitaria di FirenzeOTHER | 0 | Apr 13, 2023 | clinicaltrials |
| NCT05810805 | Measurement and Analysis of Gas Composition in Digestive Tract | unknown | — | 460 | Xiuli ZuoOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT05806151 | Prediction of True Oligo-metastatic Disease.(PREDICTION) | unknown | — | 32 | National Cancer Institute, NaplesOTHER | 1 | Apr 10, 2023 | clinicaltrials |
| NCT04492215 | General Practitioners and Participation Rate in ColoRectal Cancer Screening(AMDepCCR) | unknown | N/A | 902 | University Hospital, BrestOTHER | 1 | Apr 7, 2023 | clinicaltrials |
| NCT05803746 | PD-L2 Targeting Nanobody Radiotracer for PET Imaging of Solid Tumor | unknown | N/A | 20 | Peking University Cancer Hospital & InstituteOTHER | 1 | Apr 7, 2023 | clinicaltrials |
| NCT05133544 | Endocuff With or Without AI-assisted Colonoscopy | unknown | N/A | 656 | The University of Hong KongOTHER | 1 | Apr 6, 2023 | clinicaltrials |
| NCT03391934 | Comparing Efficacy and Safety of Cetuximab (CinnaGen) Versus Erbitux® (Merck) in Metastatic Colorectal Cancer | unknown | Phase 3 | 234 | CinnagenINDUSTRY | 1 | Apr 5, 2023 | clinicaltrials |
| NCT05798884 | Electro-acupuncture for the Prevention and Treatment of Oxaliplatin-induced Neurotoxicity in Colorectal Cancer Patients | unknown | N/A | 150 | Hong Kong Baptist UniversityOTHER | 1 | Apr 5, 2023 | clinicaltrials |
| NCT05799443 | Efficacy and Safety of SBRT Followed by Tislelizumab Plus Cetuximab and Irinotecan in Patients With Previously Treated RAS Wild-type Advanced Refractory Colorectal Cancer | unknown | Phase 2 | 23 | Fujian Cancer HospitalOTHER_GOV | 0 | Apr 5, 2023 | clinicaltrials |
| NCT05797064 | Establishment of a Feasibility Model for NOSE Surgery Based on Machine Learning | unknown | — | 460 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Apr 4, 2023 | clinicaltrials |
| NCT05797883 | FOLFOX/FOLFIRI Containing Levofolinic Acid (Zuoyu ®) in the Treatment of Unresectable or Metastatic Colorectal Cancer | unknown | Phase 2 | 30 | China Medical University, ChinaOTHER | 1 | Apr 4, 2023 | clinicaltrials |
| NCT05794737 | Immunohistochemical Expression of Inhibin Beta A (INHBA) in Colorectal Carcinoma | unknown | — | 60 | Sohag UniversityOTHER | 1 | Apr 3, 2023 | clinicaltrials |
| NCT05795010 | MRD Test in Common Risk Stage II Colorectal Cancer(HuaMC-1) | unknown | — | 60 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Apr 3, 2023 | clinicaltrials |
| NCT05795725 | Evaluation of the Diagnostic Potential of Artificial Intelligence-assisted Fecal Microbiome Testing for Colon Cancer | unknown | N/A | 1,000 | Istanbul Medipol University HospitalOTHER | 1 | Apr 3, 2023 | clinicaltrials |
| NCT05278351 | Tislelizumab Plus Cetuximab and Irinotecan vs Third-line Standard-of-care in Refractory mCRC | unknown | Phase 2 | 87 | Shanghai Zhongshan HospitalOTHER | 1 | Mar 31, 2023 | clinicaltrials |
| NCT05516641 | Prebiotics in Rectal Cancer | unknown | N/A | 20 | Ochsner Health SystemOTHER | 1 | Mar 31, 2023 | clinicaltrials |
| NCT05546892 | Short-term Outcomes of Full Bowel Preparation (MBP+OA) for Colon Cancer Resections Versus no Bowel Preparation(COLRABI) | unknown | N/A | 586 | N.N. Petrov National Medical Research Center of OncologyOTHER | 1 | Mar 29, 2023 | clinicaltrials |
| NCT05143099 | Phase II Study of Tislelizumab Combined With Cetuximab and Irinotecan in the Treatment of Recurrent, Refractory mCRC | unknown | Phase 2 | 35 | Shanghai Zhongshan HospitalOTHER | 1 | Mar 28, 2023 | clinicaltrials |
| NCT03602677 | Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic Leakage(ICG-COLORAL) | unknown | N/A | 1,062 | Oulu University HospitalOTHER | 1 | Mar 27, 2023 | clinicaltrials |
| NCT05045976 | Efficacy of Web-based Self-management Support Intervention on Health Outcomes in Patients With Colorectal Cancer | unknown | N/A | 160 | National Taipei University of Nursing and Health SciencesOTHER | 1 | Mar 27, 2023 | clinicaltrials |
| NCT01628211 | Second Look Laparoscopy in Colorectal Cancer(HIPEC) | unknown | Phase 2 | 140 | National Cancer Institute, NaplesOTHER | 1 | Mar 24, 2023 | clinicaltrials |
| NCT01651013 | Observational Study on Treatment of Metastatic Colorectal Cancer and the Role of K-Ras(CALLAS) | unknown | — | 500 | National Cancer Institute, NaplesOTHER | 1 | Mar 24, 2023 | clinicaltrials |
| NCT01651026 | Multicenter Cohort Prospective Study on Multidisciplinary Treatment of Rectal Cancer(CROSS-1) | unknown | — | 600 | National Cancer Institute, NaplesOTHER | 1 | Mar 24, 2023 | clinicaltrials |
| NCT01801904 | A Phase 2 Study of Panitumumab in Patients With Cetuximab-refractory Metastatic Colorectal Cancer(PACER) | unknown | Phase 2 | 52 | National Cancer Institute, NaplesOTHER | 1 | Mar 24, 2023 | clinicaltrials |
| NCT01898104 | Preoperative Valproic Acid and Radiation Therapy for Rectal Cancer(V-shoRT-R3) | unknown | Phase 1 / Phase 2 | 152 | National Cancer Institute, NaplesOTHER | 1 | Mar 24, 2023 | clinicaltrials |
| NCT02618850 | PET/CT Scan as a Tool to Rationalize the Treatment of Patients With Advanced ColoRectal Cancer Undergoing First-line Medical Treatment(PETRA2 - CRC) | unknown | N/A | 260 | National Cancer Institute, NaplesOTHER | 1 | Mar 24, 2023 | clinicaltrials |
| NCT02619435 | Regorafenib Monotherapy as Second-line Treatment of Patients With RAS-mutant Advanced Colorectal Cancer(STREAM) | unknown | Phase 2 | 46 | National Cancer Institute, NaplesOTHER | 1 | Mar 24, 2023 | clinicaltrials |
| NCT05115786 | Cohort Study to Evaluate the Relapse Risk Test in Colorectal Cancer | unknown | — | 1,000 | HBI Solutions Inc.INDUSTRY | 0 | Mar 23, 2023 | clinicaltrials |
| NCT03038256 | Effect of Concurrent Capecitabine-based Long-term Radiotherapy Followed by XELOX Plus TME in Patients With High Risk Rectal Cancer: a Multi-centers, Randomized Controlled, Open-Label Trial(EXPLORE) | unknown | Phase 2 | 244 | Peking University People's HospitalOTHER | 1 | Mar 22, 2023 | clinicaltrials |
| NCT05633342 | Project CADENCE (CAncer Detected Early caN be CurEd)(CADENCE) | unknown | — | 15,000 | MiRXES Pte LtdINDUSTRY | 1 | Mar 20, 2023 | clinicaltrials |
| NCT02032953 | Enhancing the Anabolic Effect of Perioperative Nutrition With Insulin While Maintaining Normoglycemia | unknown | Phase 4 | 24 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Mar 17, 2023 | clinicaltrials |
Data updated 23 days agoSource updated May 11, 2023source: clinicaltrials